Martin O’Kane Novartis Pharmaceuticals
Martin O’Kane BSc, PhD is Regional (Europe) Head of Policy & Liaison for Novartis Pharmaceuticals. He has over 20 years regulatory experience, including 17 years working for the UK Medicines and Healthcare products Regulatory Agency (MHRA), the majority of which was in the clinical trials field, including scientific assessment of trial applications and development of policy, guidance, and legislation relevant to the UK’s exit from the EU and the UK response to COVID-19. Martin is vice-chair of the European Federation of Pharmaceutical Industries Associations (EFPIA) Clinical Research Excellence Group. He holds a degree in Pharmacy from University of Aston, UK and a PhD in neuropharmacology from University of Glasgow, UK. .